Effects of photodynamic therapy for superficial esophageal squamous cell carcinoma in vivo and in vitro

Oncology Letters

Volumn 1, Issue 5, 2010, Pages 877-882

  Kawazoe, Kaoru ^a   Isomoto, Hajime ^a   Yamaguchi, Naoyuki ^a   Inoue, Naoki ^a   Uehara, Ryohei ^a   Matsushima, Kayoko ^a   Ichikawa, Tatsuki ^a   Takeshima, Fuminao ^a   Nonaka, Takashi ^a   Nanashima, Atsushi ^a   Nagayasu, Takeshi ^a   Uehara, Masataka ^a   Asahina, Izumi ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Esophageal squamous cell carcinoma; Photodynamic therapy

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; FLUOROURACIL; PHOTOFRIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CYTOTOXICITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PHOTODYNAMIC THERAPY;

EID: 77957592820     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol_00000155     Document Type: Article

References (24)

1. Cooper JS, Guo MD, Herskovic A, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281: 1623-1627, 1999.
2. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
3. Ishikura S, Nihei K, Ohtsu A, et al: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21: 2697-2702, 2003.
4. Swisher SG, Wynn P, Putnam JB, et al: Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123: 175-183, 2002.
5. Hattori S, Muto M, Ohtsu A, et al: EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 58: 65-70, 2003.
6. Gotoda T, Kondo H, Ono H, et al: A new endoscopic mucosal resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc 50: 560-563, 1999.
7. Isomoto H and Yamaguchi N: Endoscopic submucosal dissection in the era of proton pump inhibitors. J Clin Biochem Nutr 44: 205-211, 2009.
8. Fujishiro M, Kodashima S, Goto O, et al: Endoscopic submucosal dissection for esophageal squamous cell neoplasms. Dig Endosc 21: 109-115, 2009.
9. Isomoto H, Nishiyama H, Yamaguchi N, et al: Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy 41: 679-683, 2009.
10. Wolfsen HC: Uses of photodynamic therapy in premalignant and malignant lesions of the gastrointestinal tract beyond the esophagus. J Clin Gastroenterol 39: 653-664, 2005.
11. Robertson CA, Evans DH and Abrahamse H: Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 96: 1-8, 2009.
12. Hahn SM, Putt ME, Metz J, et al: Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res 12: 5464-5470, 2006.
13. Keeley SB, Pennathur A, Gooding W, Landreneau RJ, Christie NA and Luketich J: Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 14: 2406-2410, 2007.
14. Yano T, Muto M, Minashi K, Ohtsu A and Yoshida S: Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 62: 31-36, 2005.
15. Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K and Hayashi T: High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutat Res 63: 55-61, 2007.
16. Fujii M, Kochi M and Takayama T: Recent advances in chemotherapy for advanced gastric cancer in Japan. Surg Today 40: 295-300, 2010.
17. Nonaka M, Ikeda H and Inokuchi T: Effect of combined photodynamic and chemotherapeutic treatment on lymphoma cells in vitro. Cancer Lett 184: 171-178, 2002.
18. Veinot JP and Edwards WD: Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol 27: 766-773, 1996.
19. Ohtsu A, Yoshida S and Saijo N: Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol 24: 2188-2196, 2006.
20. Plaetzer K, Krammer B, Berlanda J, Berr F and Kiesslich T: Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci 24: 259-268, 2009.
21. Wang J and Yi J: Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7: 1875-1884, 2008.
22. Park S, Hong SP, Oh TY, Bang S, Chung JB and Song SY: Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells. Photochem Photobiol Sci 7: 769-774, 2008.
23. Zimmermann A, Walt H, Haller U, Baas P and Klein SD: Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient. Cancer Chemother Pharmacol 51: 147-154, 2003.
24. Takahira K, Sano M, Arai H and Hanai H: Apoptosis of gastric cancer cell line MKN45 by photodynamic treatment with photofrin. Lasers Med Sci 19: 89-94, 2004.